Leo Wealth LLC’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Leo Wealth LLC's NVS Position: Q1 2026 in Review
Leo Wealth LLC reduced its Novartis (NVS) stake by 3.4% in Q1 2026, selling an estimated $86.1K and leaving 15,866 shares worth $2.42M. The position accounts for 0.18% of the portfolio, ranked #104.
Leo Wealth LLC first reported a position in NVS in Q4 2023 and has held it in 10 quarters since. 1,599 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Leo Wealth LLC held 15,866 shares of Novartis worth $2.42M as of Q1 2026.
- Leo Wealth LLC sold 562 Novartis shares in Q1 2026, an estimated $86.1K.
- Novartis made up 0.18% of Leo Wealth LLC's portfolio in Q1 2026, its #104 holding.
- Leo Wealth LLC first reported a position in Novartis in Q4 2023 and has held it in 10 quarters since.
- 1,599 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.